A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-11
DOI
10.1038/s41467-021-23036-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
- (2020) Luciano Gattinoni et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Complement activation in patients with COVID-19: A novel therapeutic target
- (2020) Massimo Cugno et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The case of Complement activation in COVID-19 multiorgan impact
- (2020) Marina Noris et al. KIDNEY INTERNATIONAL
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
- (2020) Sisi Kang et al. Acta Pharmaceutica Sinica B
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: Complement, Coagulation, and Collateral Damage
- (2020) Martin W. Lo et al. JOURNAL OF IMMUNOLOGY
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
- (2020) Vijendra Ramlall et al. NATURE MEDICINE
- Architecture and self‐assembly of the SARS‐CoV ‐2 nucleocapsid protein
- (2020) Qiaozhen Ye et al. PROTEIN SCIENCE
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
- (2020) PJ Klasse et al. eLife
- ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
- (2020) Asmaa Hachim et al. NATURE IMMUNOLOGY
- Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
- (2020) Kathleen M. McAndrews et al. JCI Insight
- SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs
- (2020) Theodora Myrto Perdikari et al. EMBO JOURNAL
- Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid
- (2020) Christiane Iserman et al. MOLECULAR CELL
- Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
- (2016) K. Stettler et al. SCIENCE
- Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4
- (2011) Renee C. Duncan et al. MOLECULAR IMMUNOLOGY
- Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting
- (2011) Lynn Morris et al. PLoS One
- H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination
- (2011) M. Anthony Moody et al. PLoS One
- Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region
- (2010) Nathan I Nicely et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
- (2009) Hua-Xin Liao et al. JOURNAL OF VIROLOGICAL METHODS
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
- (2009) Kenneth Smith et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More